BioJapan 2020に出展します。 | Middle Molecule IT-based Drug Discovery Laboratory

The "Program to Industrialize an Innovative Middle Molecule Drug Discovery Flow through Fusion of Computational Drug Design and Chemical Synthesis Technology," which were supported from MEXT with "Program for Building Regional Innovation Ecosystems" has finished on March 31st, 2022. The contents for the program are archived here.
The Middle Molecule IT-based Drug Discovery Laboratory (MIDL) is still running as one of the "Innovation Research Initiatives" at Tokyo Institute of Technology. New information is uploaded on the new website.

MIDLは BioJapan 2020 に神奈川・横浜・川崎パビリオン（小間番号：D-27）より出展します。
ご来場の際は是非お立ち寄りください。

日付：2020年10月14日（水）～16日（金）
時刻：10:00～17:00
場所：パシフィコ横浜展示ホール